Hyperphosphatemia in end-stage renal disease-Reference-Cited by-同舟云学术

Hyperphosphatemia in end-stage renal disease

Published:2002-07 Issue:3 Volume:9 Page:184-192
ISSN:1073-4449
Container-title:Advances in Renal Replacement Therapy
language:en
Short-container-title:Advances in Renal Replacement Therapy

Author:

Indridason Olafur S.,Quarles L.Darryl

Publisher

Elsevier BV

Subject

Nephrology

Reference77 articles.

1. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998

2. Prevention and management of renal osteodystrophy in dialysis patients;Indridason,1998

3. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender;Indridason;J Clin Endocrinol Metabol,1998

4. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

5. Myocardial calcification and cardiac dysfunction in chronic renal failure;Rostand;Am J Med,1988

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Handling of Phosphate and Sulfate;Comprehensive Physiology;2014-03-19

2. Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis – system review of lanthanum carbonate;Renal Failure;2013-09-02

3. Treatment Of Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD);Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism;2013-07-19

4. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease;Current Opinion in Nephrology & Hypertension;2013-07

5. Impact of Frequent Nocturnal Hemodialysis on Myocardial Mechanics and Cardiomyocyte Gene Expression;Circulation: Cardiovascular Imaging;2012-07